- Mechanism
- Inhibits Bax-induced apoptosis and activates STAT3/ERK1/2
- Route
- subcutaneous
- Half-life
- Unknown (short endogenous, extended in analogs)
- Legal status
- Research Only
Overview
Humanin is a naturally occurring, mitochondrial-derived peptide recognized for its profound cytoprotective and anti-aging properties. It functions by shielding cells from oxidative stress and preventing apoptosis, playing a critical role in cellular survival and tissue repair. Research indicates that Humanin benefits extend to neuroprotection, cardiovascular health, and metabolic regulation, making it a significant target in age-related disease studies. As a research-only compound, the Humanin peptide offers promising therapeutic potential for mitigating mitochondrial dysfunction and promoting longevity.
Potential Benefits
- Neuroprotection and Cognitive Support: Research shows the Humanin peptide protects neurons from apoptosis and oxidative damage, highlighting its potential in Alzheimer's disease models (Niikura T, 2022).
- Cardiovascular Health: The peptide demonstrates cardio-protective effects during myocardial ischemia-reperfusion by reducing cellular death and tissue damage (Gong et al., 2022).
- Anti-Aging and Cellular Senescence: Humanin and its analogs help ameliorate cellular senescence and age-related pathophysiological changes by preserving mitochondrial function (Coradduzza et al., 2023).
- Metabolic Regulation: Studies indicate that Humanin interacts with IGF-I pathways to regulate metabolism and improve insulin sensitivity in various tissues (Xiao et al., 2016).
- Endothelial Function and Vascular Repair: Specific analogs like [Gly14]-Humanin have been shown to reduce high glucose-induced endothelial senescence via SIRT6 activation (Li et al., 2024).
- Reproductive Health Support: Emerging evidence suggests Humanin plays a regulatory role in reproductive tissues by protecting against oxidative stress and apoptosis (Lei & Rao, 2022).
Side Effects
Common side effects:
- Injection site redness or mild irritation
- Temporary localized swelling
- Mild fatigue post-administration
- Transient headaches
Rare or serious side effects:
- Unintended interactions with IGF-I signaling pathways
- Potential alterations in glucose metabolism
- Unknown long-term effects on cellular proliferation
Humanin is not FDA-approved and is intended for research purposes only. Consult a qualified healthcare provider before use.
Mechanism of Action
Mitochondrial protection is the primary mechanism by which the Humanin peptide exerts its cytoprotective effects. It binds to specific intra- and extracellular receptors, including the Bax protein, to inhibit Bax-induced apoptosis and prevent the release of cytochrome c from mitochondria (Hazafa et al., 2021). This blockade effectively halts the programmed cell death cascade triggered by severe oxidative stress or ischemic injury.
Receptor-mediated signaling further amplifies Humanin benefits across various tissues. By interacting with cell surface receptors such as the CNTF receptor complex and FPRL-1, Humanin activates survival cascades like the STAT3 and ERK1/2 pathways (Matsuoka & Hashimoto, 2010). These signaling cascades promote cellular resilience, enhance metabolic efficiency, and facilitate tissue repair in aging or damaged systems.
Origin & History
Discovery of Humanin occurred in 2001 when researchers identified it in the surviving brain cells of Alzheimer's disease patients, marking it as the first known mitochondrial-derived peptide. This groundbreaking discovery shifted scientific focus toward the mitochondrial genome's role in producing biologically active peptides that regulate cellular survival and aging (Karachaliou & Livaniou, 2023). Since then, researchers have developed various analogs, such as [Gly14]-Humanin, to enhance its stability and potency for experimental applications.
Clinical and regulatory milestones have expanded to investigate Humanin's role in various systemic conditions, though it remains strictly an investigational compound. While it is not approved by the FDA for human use, ongoing clinical trials are evaluating its diagnostic and therapeutic potential, such as its role in acute kidney injury (NCT06105229) and cardiac operations (NCT03431844).